AAAAAA
Results:
1-24
|
Results: 24
Authors:
FRIDRIK MA
JAGER G
KIENZER HR
HAUSMANINGER H
OPPITZ P
KRIEGER O
ZABERNIGG A
LANG A
NEUBAUER M
WEIDINGER G
SCHILLER L
SEEWANN HL
CHOTT A
LINKESCH W
Citation: Ma. Fridrik et al., EFFICACY AND TOXICITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) - 2 H INFUSION FOR 5 DAYS - AS FIRST-LINE TREATMENT FOR ADVANCED LOW-GRADE NON-HODGKINS-LYMPHOMA, European journal of cancer, 34(10), 1998, pp. 1560-1564
Authors:
KRIEGER O
KASPARU H
GIRSCHIKOFSKY M
BETTELHEIM P
KOLB A
ZACH O
LUTZ D
Citation: O. Krieger et al., PURE RED-CELL APLASIA (PRCA) FOLLOWING PERIPHERAL STEM-CELL TRANSPLANTATION - A CASE-REPORT, Bone marrow transplantation, 21, 1998, pp. 17-17
Authors:
FRIDRIK MA
GREIL R
HAUSMANINGER H
KRIEGER O
OPPITZ P
STOGER M
KLOCKER J
NEUBAUER M
HELM W
PONT J
FAZENY B
HUDEC M
SIMONITSCH I
RADASZKIEWICZ T
Citation: Ma. Fridrik et al., RANDOMIZED OPEN-LABEL PHASE-III TRIAL OF CEOP IMVP-DEXA ALTERNATING CHEMOTHERAPY AND FILGRASTIM VERSUS CEOP/IMVP-DEXA ALTERNATING CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - A MULTICENTER TRIAL BY THE AUSTRIAN WORKING GROUP FOR MEDICAL TUMOR-THERAPY/, Annals of hematology, 75(4), 1997, pp. 135-140
Authors:
FRIDRIK MA
JAGER G
BALDINGER C
KRIEGER O
CHOTT A
BETTELHEIM P
Citation: Ma. Fridrik et al., FIRST-LINE TREATMENT OF WALDENSTROMS-DISEASE WITH CLADRIBINE, Annals of hematology, 74(1), 1997, pp. 7-10
Authors:
KRIEGER O
STUMM M
Citation: O. Krieger et M. Stumm, HFS - A PERFORMANCE-ORIENTED FLEXIBLE FILE SYSTEM BASED ON BUILDING-BLOCK COMPOSITIONS, ACM transactions on computer systems, 15(3), 1997, pp. 286-321
Authors:
LINK H
WANDT H
SCHONROCKNABULSI P
EHNINGER G
FRANKE A
GACKLE R
GEER T
STROBEL G
LINKESCH W
KRIEGER O
NIEDERWIESER D
NIKIFORAKIS E
OHL S
OTREMBA B
PITTERMANN E
SCHMIDT H
TISCHLER J
WEISS J
WILHELM M
BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED RANDOMIZED TRIAL, Experimental hematology, 25(8), 1997, pp. 35-35
Authors:
KRIEGER O
KASPARU H
GIRSCHIKOFSKY M
OPPITZ P
BETTELHEIM P
LUTZ D
Citation: O. Krieger et al., THE CLAEG-PROTOCOL - AN EFFECTIVE TREATMENT FOR HIGH-RISK MYELOID LEUKEMIAS, Blood, 90(10), 1997, pp. 3835-3835
Authors:
KASPARU H
KRIEGER O
GIRSCHIKOFSKY M
KOLB A
BETTELHEIM P
LUTZ D
Citation: H. Kasparu et al., FACTORS INFLUENCING THE TIMING OF PERIPHERAL-BLOOD STEM-CELL COLLECTION (PBSC), Transfusion science, 17(4), 1996, pp. 595-600
Authors:
BRUGIATELLI M
HOLOWIECKA B
DMOSZYNSKA A
KRIEGER O
PLANINCPERAICA A
LABAR B
CALLEA V
MORABITO F
JAKSIC B
HOLOWIECKI J
LUTZ D
Citation: M. Brugiatelli et al., 2-CHLORODEOXYADENOSINE TREATMENT IN NON-HODGKINS-LYMPHOMA AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO CONVENTIONAL CHEMOTHERAPY - RESULTS OF A MULTICENTRIC EXPERIENCE, Annals of hematology, 73(2), 1996, pp. 79-84
Authors:
LABAR B
MASSZI T
MORABITO F
MISTRIK M
HOLOWIECKI J
BOGDANIC V
NEMET D
MRSIC M
KRIEGER O
LUTZ D
Citation: B. Labar et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA - IGCI EXPERIENCE, Bone marrow transplantation, 17(6), 1996, pp. 1009-1012
Authors:
SCHMITT K
ZOUBEK A
SCHWARZ R
TULZER G
KOLLER E
KRIEGER O
LUTZ D
GADNER H
Citation: K. Schmitt et al., ALL-TRANS-RETINOIC ACID AND SHOUT-TIME, HIGH-DOSE CYTARABINE IN 2 CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA, Medical and pediatric oncology, 26(4), 1996, pp. 254-257
Authors:
KRIEGER O
KASPARU H
GIRSCHIKOFSKY M
LUTZ D
Citation: O. Krieger et al., CLADRIBINE (2-CDA) IN COMBINATION WITH ARA-C - ETOPOSIDE AND G-CSF ISEFFECTIVE IN SECONDARY OR RELAPSED ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 3422-3422
Authors:
LINK H
WANDT H
SCHONROCKNABULSI P
EHNINGER G
FRANKE A
GACKLE R
GEER T
STROBEL G
LINKESCH W
KRIEGER O
NIEDERWIESER D
NIKIFORAKIS E
OHL S
OTREMBA B
PITTERMANN E
SCHMIDT H
TISCHLER J
WEISS J
WILHELM M
BADRI N
Citation: H. Link et al., G-CSF (LENOGRASTIM) AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - APLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 2654-2654
Authors:
PFEILSTOCKER M
GRILL R
KOLLER E
KRIEGER O
PITTERMANN E
KARLIC H
Citation: M. Pfeilstocker et al., FMS HEMIZYGOSITY IN MYELOID DYSPLASIA AND ACUTE MYELOID-LEUKEMIA WITHCHROMOSOMAL ABERRATION DEL(5)(Q) DEMONSTRATED BY POLYMERASE CHAIN-REACTION, Journal of molecular medicine, 73(8), 1995, pp. 403-407
Authors:
KOLLER E
KARLIC H
KRIEGER O
MISTRIK M
GADNER H
LUTZ D
HEINZ R
MICHLMAYR G
PITTERMANN E
Citation: E. Koller et al., EARLY DETECTION OF MINIMAL RESIDUAL DISEASE BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION PREDICTS RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA, Annals of hematology, 70(2), 1995, pp. 75-78
Authors:
UNRAU RC
KRIEGER O
GAMSA B
STUMM M
Citation: Rc. Unrau et al., HIERARCHICAL-CLUSTERING - A STRUCTURE FOR SCALABLE MULTIPROCESSOR OPERATING SYSTEM-DESIGN, Journal of supercomputing, 9(1-2), 1995, pp. 105-134
Authors:
SCHEINECKER C
STROBL H
FRITSCH G
CSMARITS B
KRIEGER O
MAJDIC O
KNAPP W
Citation: C. Scheinecker et al., GRANULOMONOCYTE-ASSOCIATED LYSOSOMAL PROTEIN EXPRESSION DURING IN-VITRO EXPANSION AND DIFFERENTIATION OF CD34(+) HEMATOPOIETIC PROGENITOR CELLS, Blood, 86(11), 1995, pp. 4115-4123
Authors:
FRIDRIK MA
LINKESCH W
JAGER G
KIENZER HJ
HAUSMANINGER H
KRIEGER O
NEUBAUER M
GATTRINGER C
OPPITZ P
SCHILLER L
Citation: Ma. Fridrik et al., RESPONSE AND TOXICITY OF CLADRIBINE (2-CDA) AS FIRST-LINE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL) - PRELIMINARY DATA OF AN AUSTRIAN MULTICENTER TRIAL, Blood, 86(10), 1995, pp. 210-210
Authors:
KANDIOLER D
KRIEGER O
NOWOTNY H
LUTZ D
Citation: D. Kandioler et al., CLONAL EVOLUTION IN A TRANSFORMING 5Q- SYNDROME, Leukemia, 8(4), 1994, pp. 711-712
Authors:
SCHMITT K
SCHWARZ R
TULZER G
KRIEGER O
ZOUBEK A
GADNER H
Citation: K. Schmitt et al., TOXICITY OF TRETINOIN IN ACUTE PROMYELOCYTIC LEUKEMIA, Lancet, 343(8893), 1994, pp. 361-361
Authors:
KRIEGER O
STUMM M
UNRAU R
Citation: O. Krieger et al., THE ALLOC STREAM FACILITY - A REDESIGN OF APPLICATION-LEVEL STREAM I O/, Computer, 27(3), 1994, pp. 75-82
Authors:
FRIDRIK MA
GREIL R
HAUSMANINGER H
KRIEGER O
OPPITZ P
STOGER M
KLOCKER J
NEUBAUER M
DITTRICH C
HELM W
Citation: Ma. Fridrik et al., VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN THE TREATMENT OF AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL)WITH AN INTENSIVE WEEKLY CHEMOTHERAPY SCHEDULE - AN AUSTRIAN RANDOMIZED MULTICENTER TRIAL, Blood, 84(10), 1994, pp. 10000023-10000023
Authors:
FELZMANN T
GISSLINGER H
KRIEGER O
MAJDIC O
LUDWIG H
KOLLER U
Citation: T. Felzmann et al., IMMUNOPHENOTYPIC CHARACTERIZATION OF MYELOMONOCYTIC CELLS IN PATIENTSWITH MYELODYSPLASTIC SYNDROME, British Journal of Haematology, 84(3), 1993, pp. 428-435
Authors:
LINK H
FAUSER A
HUBNER G
BACIGALUPO A
BOOGAERTS M
BURDACH S
CARELLA A
FERRANT A
GOLDSTONE A
GORIN N
KRIEGER O
LINKESCH W
MANDELLI F
MCCANN S
REIFFERS J
SLAVIN S
STEWARD W
TURA S
ZINTL F
SCHINDELKUNZEL F
HEINRICHS H
Citation: H. Link et al., CLINICAL BONE-MARROW TRANSPLANTATION .3. RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE PLACEBO-CONTROLLED TRIAL IN EUROPE, Blood, 82(10), 1993, pp. 10000284-10000284
Risultati:
1-24
|